Intuity Medical, Inc.: Series D $64M

Posted in I - Series D, Q - 1Q10, R - WEST, X - Device (Diabetes), X - Device (Diagnostic), XX - CA

Intuity Medical (Sunnyvale, CA) a clinical-stage diagnostic device company focused on all-in-one blood sample collection and glucose analysis, closed a Series D financing. Participants include Venrock, Emergent Medical Partners, Investor Growth Capital, Thomas McNerney and Partners, U.S. Venture Partners and Versant Ventures.

Jan

2010

Receptos, Inc.: Series A $25M

Posted in I - Series A, Q - 4Q09, R - WEST, X - Autoimmune, X - GPCR, X - Immunology, XX - CA

Receptos (San Diego, CA) a preclinical stage biopharmaceutical company focused on structural biolog GPCR approaches targeting autoimmune disease, closed a $25M Series A financing. Participants include ARCH Venture Partners, Flagship Ventures, Lilly Ventures and Venrock.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Jan

2010

Fate Therapeutics, Inc.: Series B $30M

Posted in I - Series B, Q - 4Q09, R - WEST, X - Stem Cell, XX - CA

Fate Therapeutics (La Jolla, CA) a pre-clinical biopharma company focused on developing small molecule and biologic drug candidates to modulate stem cell pathways to stimulate tissue regeneration and blocking cancer growth, closed a $30M Series B financing. Participants include OVP Venture Partners, ARCH Venture Partners, Polaris Venture Partners and Venrock.

Note: 2009 Year-in-Review Trend Analysis Coming [...]

to top of page...